Onvansertib, CAS [[1034616-18-6]]

Produktübersicht

• Artikelname: Onvansertib, CAS [[1034616-18-6]]
• Artikelnummer: AMO-M13718
• Hersteller Artikelnummer: M13718
• Alternativnummer: AMO-M13718-5MG,AMO-M13718-10MG,AMO-M13718-25MG,AMO-M13718-50MG
• Hersteller: Abmole Bioscience
• Kategorie: Biochemikalien
• Alternative Synonym: PCM-075, NMS-1286937, NMS-P937

Produktbeschreibung

Onvansertib (PCM-075, NMS-1286937, NMS-P937) is a first-in-class, third-generation, oral, highly selective PLK1 inhibitor that induces tumor cell arrest in the G2/M phase and triggers apoptosis. It has a median IC50=136nM against a variety of CRC cell lines and inhibits xenograft models such as HT-29, HCT-116, and Colo-205 well.

Produkteigenschaften

• Molekulargewicht: 532.52
• Reinheit: >99%
• CAS Nummer: [1034616-18-6]
• Formel: C24H27F3N8O3
• Target-Kategorie: PLK